MARAVAI LIFESCIENCES HOLDINGS, INC.·4

Jun 10, 5:07 PM ET

Brust Bernd 4

4 · MARAVAI LIFESCIENCES HOLDINGS, INC. · Filed Jun 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Maravai (MRVI) CEO Bernd Brust Withholds 351,001 Shares

What Happened

  • Bernd Brust, CEO of Maravai Lifesciences (MRVI), had 351,001 shares withheld on June 8, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units. The shares were valued at $5.02 each, totaling approximately $1,762,025. This was a tax-withholding disposition (not an open-market sale).

Key Details

  • Transaction date: 2026-06-08; Filing date: 2026-06-10 (timely).
  • Price per share: $5.02; Total value withheld: ~$1,762,025.
  • Shares involved: 351,001 shares were withheld/disposed to cover taxes.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnote: F1 — shares were withheld to satisfy tax withholding obligations upon RSU vesting.
  • Filing timeliness: No late filing indicated.

Context

  • This was a tax-withholding action (code F) following RSU vesting — effectively a cashless settlement where shares are retained by the company to cover required taxes. Such withholdings are routine and don’t necessarily indicate insider buying or selling sentiment.

Insider Transaction Report

Form 4
Period: 2026-06-08
Brust Bernd
DirectorChief Executive Officer
Transactions
  • Tax Payment

    Class A Common Stock

    [F1]
    2026-06-08$5.02/sh351,001$1,762,0251,648,999 total
Holdings
  • Class A Common Stock

    (indirect: By Trust)
    466,771
Footnotes (1)
  • [F1]Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.
Signature
/s/ Kurt Oreshack, by power of attorney for Bernd Brust|2026-06-10

Documents

1 file
  • 4
    wk-form4_1781125627.xmlPrimary

    FORM 4